Skip to Main Content

LABU  Direxion Daily S&P Biotech Bull 3X…
Exchange-Traded Fund
NYSE Arca

Morningstar Summary

Ratings & Reports

  • Overall
    as of --
    Star Rating: 0Not Rated
    Out of -- funds
  • 3 Year
    Star Rating: 0Not Rated
    Out of -- funds
  • 5 Year
    Star Rating: 0Not Rated
    Out of -- funds
  • 10 Year
    Star Rating: 0Not Rated
    Out of -- funds

Historical Risk

  • Low
  • Below Average
  • Avg
  • Above Average
  • High

Historical Return

  • Low
  • Below Average
  • Avg
  • Above Average
  • High

Morningstar Style Box

Market Cap vs. Investment Style
Selected Values: Investment Style: Mid, Market Cap: Growth
Value
Blend
Growth
Large
Mid
Small

Price Movement of LABU

Chart for Price Movement
LABU is up 1.83% over the last 3 days.
Bid/Ask1-- / --
Open$0.00
Previous Close$77.39
Day Low/High
Last Price
$77.39  0% or $32,845.39 from its Day low
--
--
52 Week Range
Last Price
$77.39  7% or $3.52 from its 52 Week high
$24.44
11/03/2016
$80.91
9/01/2017
Price/Earnings--
Price/Cash Flow--
Price/Revenue9.91x

Fund Detail

as of 8/31/2017

Profile

Profile
Total Net Assets$380.6 M
Premium/Discount-0.21%
Portfolio Turnover--
Total Holdings13
Fund TypeETF
Transaction FeeYes

Distributions and Yield

Distributions and Yield
Distribution Yield0.00%
Most Recent Dividend--
Previous Pay Date--
Ex-Date--
Distribution FrequencyQuarterly
SEC Yield--

Total Returns

as of 8/31/2017

Standardized Returns

Standardized Returns: Monthly
Description3 Month1 Year3 Year5 Year10 YearInception3 Month1 Year3 Year5 Year10 YearInception3 Month1 Year3 Year5 Year10 YearInception
LABU Market Price
36.32%60.03%-------26.72%79.84%109.71%-------26.46%32.12%123.42%-------35.28%
LABU NAV
36.53%60.26%-------26.72%80.06%110.17%-------26.94%31.74%122.08%-------35.82%
Trading--Leveraged Equity
Morningstar Category
------------3.07%15.53%20.57%18.63%6.36%--3.19%9.51%24.83%16.48%5.43%--
S&P 500
Index
3.43%19.49%9.87%13.79%7.42%10.63%3.01%16.23%9.54%14.34%7.61%10.61%3.09%17.90%9.61%14.63%7.18%10.60%
View Performance >

Top 5 Holdings

as of 8/31/2017
Top 5 Holdings
--S&P Biotechnology Select Industry USD11.35%
--S&P Biotechnology Select9.25%
--S&P Biotechnology Select7.65%
XBIOpens Flyout Module that includes Quote information for linked symbolSPDR® S&P Biotech ETF6.42%
--S&P Biotechnology Select5.40%
Total
40.07%
More Holdings >

Top Sectors

as of 8/31/2017
Top SectorsTop Sectors
Sector% of Holdings
Healthcare100.00%
Industrials0.00%
Real Estate0.00%
Technology0.00%
Total100.00%
Sign in to see if you own shares.
Additional Trading Options
Fund Highlights
Fund Strategy
The investment seeks daily investment results, before fees and expenses, of 300% of the daily performance of the S&P Biotechnology Select Industry Index ("index"). The fund, under normal circumstances, invests at least 80% of its net assets (plus borrowing for investment purposes) in financial instruments that provide daily leveraged exposure to the index and/or exchange-traded funds ("ETFs") that track the index. The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified.
Morningstar Category
These funds seek to generate returns equal to a fixed multiple of the short-term returns of an equity index. The compounding of short-term returns results in performance that does not correspond to those of investing in the index with external leverage. For example, a fund attempting to achieve 2 times the returns of a given index on a daily basis is unlikely to deliver anything like 2 times the index's returns over periods longer than one day. Many of these funds seek to generate a multiple of the daily or weekly return of the reference index. Trading funds are not considered suitable for a long-term investor and are designed to be used by active traders.
  • Inception Date
    05/28/2015
  • 1.09%
    Net Expense may include reimbursements or fee waivers, which may be voluntary or contractual and may expire. See prospectus for more details.
  • Gross Expense Ratio
    1.11%
  • Index Fund
    Yes
  • Leveraged Fund
    Yes
  • Socially Conscious
    No
  • Actively Managed
    No
  • Fund Family
Opens a modal dialogOpens a modal dialogOpen flyout contentOpens a new window